Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
315.00
0.00 (0.00%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.15 billion as of June 3, 2026. Its market cap has increased by 20.44% in one year.
Market Cap
8.15B
Enterprise Value
7.97B
1-Year Change
20.44%
Ranking
Category
Stock Price
$315.00
Market Cap Chart
Since June 3, 2021, Bio-Rad Laboratories's market cap has decreased from $17.31B to $8.15B, a decrease of -52.89%. That is a compound annual growth rate of -13.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 8.25B | 1.17% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.65% |
| Jun 3, 2021 | 17.31B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 16.20B |
| Smith & Nephew | 12.56B |
| Penumbra | 12.54B |
| Globus Medical | 10.62B |
| Insulet | 9.87B |
| Masimo | 9.36B |
| Bruker | 8.72B |
| Bio-Rad Laboratories | 8.19B |